Finance

Lists
ADMA:NASDAQ
ADMA Biologics Inc
$9.23
-1.70%
(-0.16) 1D
$9.20
-0.33% (-0.030)
After hours
Closed: Sep 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADMA...
Open
$9.44
High
$9.50
Low
$9.20
Mkt. cap
2.07B
Avg. vol.
2.15M
Volume
2.27M
P/E ratio
13.09
52-wk high
$20.46
52-wk low
$7.21
EPS
$0.71
Beta
0.78
Shares outstanding
223.98M
No. of employees
644
Open
$9.44
High
$9.50
Low
$9.20
Mkt. cap
2.07B
Avg. vol.
2.15M
Volume
2.27M
P/E ratio
13.09
52-wk high
$20.46
52-wk low
$7.21
EPS
$0.71
Beta
0.78
Shares outstanding
223.98M
No. of employees
644
News stories
From web sources and news partners
About ADMA Biologics Inc
CEO-
Employees644
Founded2004
HeadquartersRamsey, New Jersey, United States
SectorBiotechnology
Websiteadmabiologics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ADMA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ADMA in the last 3 months.
Highest
Current $9.23
$18.00 (+95.02%)
Average
$15.67 (+69.77%)
Lowest
$12.00 (+30.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
$12.00
+30%
08/05/2026
Gary Nachman
Canaccord Genuity
Buy
Maintained
$18.00
+95%
08/06/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$17.00
+84.2%
07/15/2026
Ryan Deschner
Raymond James
Buy
Initiated
$21.00
+127.5%
06/10/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
$21.00
+127.5%
04/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
134.22M
139.16M
114.49M
124.40M
Cost of goods sold
58.60M
50.35M
33.74M
38.12M
Cost of revenue
58.60M
50.35M
33.74M
38.12M
Research and development expenses
1.53M
1.38M
2.60M
6.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.05M
24.64M
27.80M
27.76M
Operating expense
24.61M
26.06M
30.46M
33.83M
Total operating expenses
83.21M
76.41M
64.20M
71.95M
Operating income
51.01M
62.75M
50.29M
52.44M
Other non operating income
-21.00K
-17.00K
-140.00K
-22.00K
EBT including unusual items
47.52M
61.60M
57.13M
50.24M
EBT excluding unusual items
49.69M
61.60M
49.15M
50.24M
Income tax expense
11.09M
12.22M
11.80M
12.42M
Effective tax rate
23.33%
19.83%
20.65%
24.71%
Other operating expenses
-
-
-
-
Net income
36.43M
49.38M
45.33M
37.82M
Net profit margin
27.14%
35.48%
39.59%
30.40%
Earnings per share
0.16
0.22
0.17
0.17
Interest and investment income
376.00K
487.00K
1.09M
1.24M
Interest expense
-1.68M
-1.63M
-2.10M
-3.42M
Net interest expenses
-1.30M
-1.14M
-1.01M
-2.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
53.04M
64.80M
52.13M
54.23M
Gain or loss from assets sale
-
9.00K
-7.94M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps